Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

11.42
Delayed Data
As of 11:59am ET
 -0.2199 / -1.89%
Today’s Change
8.90
Today|||52-Week Range
16.80
-27.40%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close11.64
Today’s open11.57
Day’s range11.35 - 11.62
Volume78,005
Average volume (3 months)347,082
Market cap$497.7M
Dividend yield--
Data as of 11:59am ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+22.50%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.22-1.54%
RVNCRevance Therapeutics...-0.27-1.54%
FLXNFlexion Therapeutics...-0.17-0.94%
CYNACynapsus Therapeutic...-0.01-0.02%
Data as of 12:17pm ET, 09/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts

Search for Jobs